iNtRON Biotechnology, Inc. (KOSDAQ:048530)

iNtRON Biotechnology Revenue

iNtRON Biotechnology had revenue of 1.62B KRW in the quarter ending September 30, 2025, with 34.35% growth. This brings the company's revenue in the last twelve months to 5.56B, down -35.49% year-over-year. In the year 2024, iNtRON Biotechnology had annual revenue of 6.42B, down -33.05%.

• Revenue (ttm): 5.56B
• Revenue Growth: -35.49%
• P/S Ratio: 21.04
• Revenue / Employee: 76.13M
• Employees: 73
• Market Cap: 116.95B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	6.42B	-3.17B	-33.05%
Dec 31, 2023	9.59B	-4.42B	-31.57%
Dec 31, 2022	14.01B	-15.30B	-52.21%
Dec 31, 2021	29.31B	-16.13B	-35.49%
Dec 31, 2020	45.43B	37.09B	444.28%